601 related articles for article (PubMed ID: 27730495)
1. Management of Dyslipidemia in Patients with Hypertension, Diabetes, and Metabolic Syndrome.
Srikanth S; Deedwania P
Curr Hypertens Rep; 2016 Oct; 18(10):76. PubMed ID: 27730495
[TBL] [Abstract][Full Text] [Related]
2. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW
Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
[TBL] [Abstract][Full Text] [Related]
3. [How to treat dyslipidemia in patients with metabolic syndrome].
Soška V
Vnitr Lek; 2015; 61(7-8):721-4. PubMed ID: 26375703
[TBL] [Abstract][Full Text] [Related]
4. [Diabetes and dyslipidemia: Why are they so closely related?].
Rašlová K
Vnitr Lek; 2016; 62(11):908-911. PubMed ID: 28128578
[TBL] [Abstract][Full Text] [Related]
5. Management of dyslipidemia in the metabolic syndrome: recommendations of the Spanish HDL-Forum.
Ascaso J; Gonzalez Santos P; Hernandez Mijares A; Mangas Rojas A; Masana L; Millan J; Pallardo LF; Pedro-Botet J; Perez Jimenez F; Pintó X; Plaza I; Rubiés J; Zúñiga M
Am J Cardiovasc Drugs; 2007; 7(1):39-58. PubMed ID: 17355165
[TBL] [Abstract][Full Text] [Related]
6. Drug treatment of metabolic syndrome.
Altabas V
Curr Clin Pharmacol; 2013 Aug; 8(3):224-31. PubMed ID: 22950955
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of the metabolic syndrome.
Ceska R
Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S2-4. PubMed ID: 17935057
[TBL] [Abstract][Full Text] [Related]
8. [Guidelines for the management of atherosclerotic diseases in diabetes mellitus].
Kotake H; Oikawa S
Nihon Rinsho; 2006 Nov; 64(11):2074-80. PubMed ID: 17087299
[TBL] [Abstract][Full Text] [Related]
9. The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: II. Therapeutic management of atherogenic dyslipidemia.
Ginsberg HN; Maccallum PR
J Clin Hypertens (Greenwich); 2009 Sep; 11(9):520-7. PubMed ID: 19751468
[TBL] [Abstract][Full Text] [Related]
10. Should all patients with metabolic syndrome be treated with statins?
Abate N; Chandalia M
Curr Diab Rep; 2006 Feb; 6(1):72-6. PubMed ID: 16522284
[TBL] [Abstract][Full Text] [Related]
11. Managing atherosclerosis in patients with type 2 diabetes mellitus and metabolic syndrome.
Venkatapuram S; Shannon RP
Am J Ther; 2006; 13(1):64-71. PubMed ID: 16428924
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic therapy for cardiovascular risk reduction in patients with the metabolic syndrome.
Gouni-Berthold I; Berthold HK
Curr Pharm Des; 2014; 20(31):5025-38. PubMed ID: 24320031
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome: diabetes and cardiovascular disease.
Gupta S; Gupta BM
Indian Heart J; 2006; 58(2):149-52. PubMed ID: 18989060
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Dyslipidemia in Diabetes: Recent Advances and Remaining Questions.
Chait A; Goldberg I
Curr Diab Rep; 2017 Sep; 17(11):112. PubMed ID: 28956258
[TBL] [Abstract][Full Text] [Related]
15. Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins.
Tenenbaum A; Fisman EZ; Motro M; Adler Y
Cardiovasc Diabetol; 2006 Sep; 5():20. PubMed ID: 17002798
[TBL] [Abstract][Full Text] [Related]
16. Do statins reduce events in patients with metabolic syndrome?
Towne SP; Thara E
Curr Atheroscler Rep; 2008 Feb; 10(1):39-44. PubMed ID: 18366984
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary.
; ; Grundy SM; Cleeman JI; Daniels SR; Donato KA; Eckel RH; Franklin BA; Gordon DJ; Krauss RM; Savage PJ; Smith SC; Spertus JA; Costa F
Cardiol Rev; 2005; 13(6):322-7. PubMed ID: 16708441
[No Abstract] [Full Text] [Related]
18. Type 2 diabetes mellitus, metabolic syndrome, and mixed dyslipidemia: how similar, how different, and how to treat?
Halcox J; Misra A
Metab Syndr Relat Disord; 2015 Feb; 13(1):1-21. PubMed ID: 25402738
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic approaches in the prevention of cardiovascular disease in metabolic syndrome and in patients with type 2 diabetes.
Rosenson RS; Reasner CA
Curr Opin Cardiol; 2004 Sep; 19(5):480-7. PubMed ID: 15316457
[TBL] [Abstract][Full Text] [Related]
20. [Metabolic syndrome. Part III: its prevention and therapeutic management].
Pacholczyk M; Ferenc T; Kowalski J
Postepy Hig Med Dosw (Online); 2008 Oct; 62():559-70. PubMed ID: 18936731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
